JoonHUhmMD

Neurology • Rochester, MN

Neurooncology

Professor of Neurology, Chair of Division of Neuro-Oncology, Mayo Clinic, Rochester, MN

Join to view full profile

Dr. Uhm is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Uhm's full profile

Already have an account?

Office
200 1st Street SW
Rochester, MN 55905
Is this information wrong?

Education & Training

McGill University Faculty of MedicineClass of 1992, MD

Certifications & Licensure

MN State Medical License 1999 - 2024
TX State Medical License 1997 - 2004
Royal College of Physician of CanadaNeurology

Clinical Trials

Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2001 Mar 01
Completed
Phase 2
Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2006 May 01
Completed
Phase 1
Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies Start of enrollment: 2006 Nov 01
Completed
Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab Start of enrollment: 2023 Dec 13
Recruiting
Phase 1, Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Proton versus photon craniospinal irradiation for adult medulloblastoma: A dosimetric, toxicity, and exploratory cost analysis.
Connie S Geno, Jing Qian, William S Harmsen, Michael W Ruff, Jon J Kruse, William G Breen, Mark R Waddle, Terry C Burns, Ugur T Sener, Joon H Uhm, David M Routman, Eli...> ;Neuro-Oncology Advances. 2024 Mar 8
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial.
Galanis, E., Dooley, K., Keith Anderson, S., Kurokawa, C., Carrero, X., Uhm, J., Federspiel, M., Leontovich, A., Aderca, I., Viker, K., Hammack, J., Marks, R., Robinso...> ;Nature Communications. 2024 Jan 12
Recurrent Pleomorphic Xanthoastrocytoma Presenting With Diffuse Leptomeningeal Spread.
Grigsby-Rocca, G., Bermudez, C., White, J., Neth, B., Uhm, J., Mustafa, R.> ;The Neurohospitalist. 2024 Jan 1
1 citations
Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients.
M J Webb, Bryan J Neth, Lauren M Webb, Jamie J Van Gompel, Michael J Link, Brian A Neff, Matthew L Carlson, Colin L Driscoll, Jim Dornhoffer, Michael W Ruff, Kelsey A ...> ;Neuro-Oncology Advances. 2023 Sep 22
2 citations
Management and Long-term Outcomes of Adults With Medulloblastoma: A Single-Center Experience.
Bryan J Neth, Aditya Raghunathan, Sani H Kizilbash, Joon H Uhm, William G Breen, Derek R Johnson, David J Daniels, Ugur Sener, Ivan D Carabenciov, Jian L Campian, Soum...> ;Neurology. 2023 Sep 19
3 citations
Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience.
Bryan J Neth, Mason J Webb, Jessica White, Joon H Uhm, Pavel N Pichurin, Ugur Sener> ;Journal of Neuro-Oncology. 2023 Aug 1
Clinical, Neurophysiologic, and Pathologic Features in Patients With Early-Onset Postradiation Neuropathy.
Michael Skolka, Shahar Shelly, Marcus V Pinto, Divyanshu Dubey, Tatsuya Oishi, Joon H Uhm, Ashley Santilli, Nathan P Staff, Robert J Spinner, P James B Dyck, Carrie El...> ;Neurology. 2023 Oct 3
4 citations
Genomic markers of recurrence risk in atypical meningioma following gross total resection.
Rachael A Vaubel, Rahul Kumar, Taylor M Weiskittel, Sarah Jenkins, Surendra Dasari, Joon H Uhm, Daniel H Lachance, Paul D Brown, Jamie J Van Gompel, Robert B Jenkins, ...> ;Neuro-Oncology Advances. 2023 Jan 10
2 citations
Initial results of a phase II trial ofF-DOPA PET-guided re-irradiation for recurrent high-grade glioma.
William G Breen, Ryan S Youland, Sharmila Giri, Sawyer B Jacobson, Deanna H Pafundi, Paul D Brown, Christopher H Hunt, Anita Mahajan, Michael W Ruff, Sani H Kizilbash,...> ;Journal of Neuro-Oncology. 2022 Jul 1
3 citations
Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experience.
Bryan J Neth, Samantha N Balakrishnan, Ivan D Carabenciov, Joon H Uhm, David J Daniels, Sani H Kizilbash, Michael W Ruff> ;Journal of Neuro-Oncology. 2022 Mar 1
18F-DOPA-PET-Guided Re-Irradiation for Recurrent High-Grade Glioma: Initial Results of a Phase II Trial.
William G. Breen, Ryan S. Youland, Steven R. Jacobson, Deanna H. Pafundi, Paul D. Brown, Christopher H. Hunt, Anita Mahajan, Michael W. Ruff, Sani H. Kizilbash, Joon H...> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
20 citations
IDH-wild-type glioblastoma cell density and infiltration distribution influence on supramarginal resection and its impact on overall survival: a mathematical model.
Shashwat Tripathi, Tito Vivas-Buitrago, Ricardo A. Domingo, Gaetano De Biase, Desmond A. Brown, Oluwaseun O. Akinduro, Andres Ramos-Fresnedo, Wendy Sherman, Vivek Gupt...> ;Journal of Neurosurgery. 2021 Oct 29
4 citations
A Comprehensive Study of Spindle Cell Oncocytoma of the Pituitary Gland: Series of 6 Cases and Meta-Analysis of 85 Cases.
Hirotaka Hasegawa, Jamie J. Van Gompel, Soliman Oushy, Bruce E. Pollock, Michael J. Link, Fredric B. Meyer, Irina Bancos, Dana Erickson, Caroline J. Davidge-Pitts, Jas...> ;World Neurosurgery. 2021 Feb 18
19 citations
Initial Results of a Phase 2 Trial of 18F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma
Nadia N. Laack, Deanna H. Pafundi, S. Keith Anderson, Timothy J. Kaufmann, Val J. Lowe, Christopher H. Hunt, Diane Vogen, Elizabeth Yan, Jann N. Sarkaria, Paul D. Brow...> ;International Journal of Radiation Oncology, Biology, Physics. 2020 Nov 1
Temozolomide desensitization followed by metronomic dosing in patients with hypersensitivity.
Bryan J. Neth, Michael W. Ruff, Joon H. Uhm, Derek R. Johnson, Rohit Divekar, Daniel E. Maddox> ;Cancer Chemotherapy and Pharmacology. 2020 Aug 10
5 citations
TTF-1 positive posterior pituitary tumor: Limitations of current treatment and potential new hope in BRAF V600E mutation variants.
Fakhry Dawoud, Ryan M. Naylor, Caterina Giannini, Amy A. Swanson, Fredric B. Meyer, Joon H. Uhm> ;Clinical Neurology and Neurosurgery. 2020 Jun 30
4 citations
Bevacizumab Use in Refractory Adult Pilocytic Astrocytoma: A Single-Center Case Series.
Ivan D. Carabenciov, Adip G. Bhargav, Joon H. Uhm, Michael W. Ruff> ;The Neurologist. 2019 May 1
43 citations
Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report.
Benjamin T. Himes, Michael W. Ruff, Jaimie J. Van Gompel, Sean S. Park, Evanthia Galanis, Timothy J. Kaufmann, Joon H. Uhm> ;Journal of Neurosurgery. 2019 Apr 1
3 citations
Neuro-oncology: Implications of the molecular era
Michael W. Ruff, Joon H. Uhm, Eduardo E. Benarroch> ;Neurology. 2019 Mar 19
4 citations
Anaplastic Glioma: Treatment Approaches in the Era of Molecular Diagnostics.
Michael W. Ruff, Joon H. Uhm> ;Current Treatment Options in Oncology. 2018 Oct 25
5 citations
Modern reirradiation for recurrent gliomas can safely delay tumor progression.
Ryan S. Youland, John Y. Lee, Cole R. Kreofsky, Paul D. Brown, Joon H. Uhm, Nadia N. Laack> ;Neuro-Oncology Practice. 2018 Mar 2
32 citations
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Emerging Therapies for the Treatment of Patients With Vestibular Schwannomas.
Jamie J. Van Gompel, Siviero Agazzi, Matthew L. Carlson, Dare A Adewumi, Constantinos G. Hadjipanayis, Joon H. Uhm, Jeffrey J. Olson> ;Neurosurgery. 2018 Feb 1
27 citations
Overall survival in patients with glioblastoma before and after bevacizumab approval.
Derek R. Johnson, Antonio Omuro, Arliene Ravelo, Nicolas Sommer, Annie Guerin, Raluca Ionescu-Ittu, Sherry Shi, Alex Macalalad, Joon H. Uhm> ;Current Medical Research and Opinion. 2018 May 4
11 citations
Incidence, Characteristics, and Implications of Seizures in Patients With Glioblastoma:
John Y. Shin, Sani H. Kizilbash, Steven I. Robinson, Joon H. Uhm, Aminah Jatoi> ;The American Journal of Hospice & Palliative Care. 2017 Aug 1
45 citations
Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma
Christopher S. Graffeo, Heather Leeper, Avital Perry, Joon H. Uhm, Daniel J. Lachance, Paul D. Brown, Daniel J. Ma, Jamie J. Van Gompel, Caterina Giannini, Derek R. Jo...> ;World Neurosurgery. 2017 Jul 1
Join now to see all

Press Mentions

Beating Back a Brain Tumor Amid LossJune 17th, 2019
Experts Present How Science and New Technology Are Driving New Brain Tumor Treatments and Improving Quality of LifeJuly 23rd, 2015
Brain Cancer Survival Improved Following FDA Approval of Bevacizumab, Mayo Study FindsFebruary 10th, 2016
Join now to see all

Grant Support

Epidermal Growth Factor Receptor Signaling In GliomaNational Institute Of Neurological Disorders And Stroke2004–2006
Soluble EGFR As A Potential Serum Biomarker In GliomaNational Cancer Institute2004
Epidermal Growth Factor Receptor Signaling In GliomaNational Institute Of Neurological Disorders And Stroke2002–2003